Biotalys

Biotalys EBITDA per Employee

The EBITDA per Employee of Biotalys (BTLS.BR) as of Oct 29, 2026 is -214,108.11 EUR. In the previous year, EBITDA per Employee was -182,324.32 EUR — a change of 17.43% (lower).

EBITDA per Employee

-214,108.11EUR

YoY

17.43%

Last updated:

EBITDA per Employee of Biotalys is 2025 -214,108.11 EUR. EBITDA per Employee of Biotalys was 2024 -182,324.32 EUR. It decreases by 17.43% lower compared to the previous year.

The Biotalys EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2019
-124,891.89 EUR
Jan 1, 2020
-179,405.41 EUR
Jan 1, 2021
-244,310.81 EUR
Jan 1, 2022
-304,472.97 EUR
Jan 1, 2023
-282,310.81 EUR
Jan 1, 2024
-182,324.32 EUR
Jan 1, 2025
-214,108.11 EUR
The Biotalys EBITDA per Employee history
YEAREBITDA per EmployeeYoY
-214,108.11EUR+17.43%
-182,324.32EUR-35.42%
-282,310.81EUR-7.28%
-304,472.97EUR+24.63%
-244,310.81EUR+36.18%
-179,405.41EUR+43.65%
-124,891.89EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biotalys Stock analysis

What does Biotalys do? Biotalys NV develops sustainable crop protection products, including AGROBODY Foundry, which combines active ingredients with Agrobodies as formulation agents. The company offers protein-based biocontrol solutions targeting crop pests and diseases, with a product pipeline called EvocaTM addressing key agricultural threats. Biotalys provides tools to prevent crop loss, extend post-harvest protection, and reduce food waste through its BioFungicides, BioInsecticides, and BioBactericides product lines. The company generates revenue by selling its crop protection products to agricultural stakeholders, including farmers and agribusinesses seeking sustainable pest management solutions. AGROBODY Foundry and EvocaTM are key products driving sales, while BioFungicides, BioInsecticides, and BioBactericides form the core of its product portfolio. Biotalys focuses on delivering biocontrol solutions that tackle a wide range of crop pests and diseases, appealing to environmentally conscious agricultural sectors. Biotalys' business model centers on developing and commercializing bio-based crop protection technologies. Its product pipeline, including EvocaTM and the three biocontrol categories, targets the growing market for sustainable agricultural practices. The company monetizes its technology through direct sales of its branded products to end-users in the agricultural industry, emphasizing eco-friendly alternatives to conventional pesticides. Biotalys is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biotalys stock

EBITDA per Employee of Biotalys is -214,108.11 EUR in 2025.

EBITDA per Employee of Biotalys changed from -182,324.32 EUR to -214,108.11 EUR, representing a 17.43% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Biotalys since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Biotalys historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Biotalys

All Key Metrics — Biotalys